全文获取类型
收费全文 | 2687篇 |
免费 | 210篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 75篇 |
妇产科学 | 51篇 |
基础医学 | 496篇 |
口腔科学 | 25篇 |
临床医学 | 272篇 |
内科学 | 719篇 |
皮肤病学 | 33篇 |
神经病学 | 280篇 |
特种医学 | 55篇 |
外国民族医学 | 8篇 |
外科学 | 271篇 |
综合类 | 8篇 |
预防医学 | 156篇 |
眼科学 | 51篇 |
药学 | 185篇 |
中国医学 | 7篇 |
肿瘤学 | 203篇 |
出版年
2023年 | 21篇 |
2022年 | 38篇 |
2021年 | 97篇 |
2020年 | 59篇 |
2019年 | 117篇 |
2018年 | 110篇 |
2017年 | 75篇 |
2016年 | 73篇 |
2015年 | 87篇 |
2014年 | 84篇 |
2013年 | 142篇 |
2012年 | 194篇 |
2011年 | 180篇 |
2010年 | 89篇 |
2009年 | 81篇 |
2008年 | 126篇 |
2007年 | 128篇 |
2006年 | 130篇 |
2005年 | 118篇 |
2004年 | 110篇 |
2003年 | 90篇 |
2002年 | 83篇 |
2001年 | 59篇 |
2000年 | 42篇 |
1999年 | 57篇 |
1998年 | 15篇 |
1997年 | 23篇 |
1996年 | 20篇 |
1995年 | 12篇 |
1994年 | 9篇 |
1993年 | 10篇 |
1992年 | 25篇 |
1991年 | 29篇 |
1990年 | 40篇 |
1989年 | 25篇 |
1988年 | 25篇 |
1987年 | 22篇 |
1986年 | 26篇 |
1985年 | 24篇 |
1984年 | 16篇 |
1983年 | 18篇 |
1982年 | 16篇 |
1981年 | 13篇 |
1979年 | 16篇 |
1978年 | 14篇 |
1974年 | 11篇 |
1973年 | 9篇 |
1971年 | 9篇 |
1970年 | 10篇 |
1969年 | 9篇 |
排序方式: 共有2909条查询结果,搜索用时 31 毫秒
141.
Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis 总被引:31,自引:0,他引:31
Rachmilewitz D Katakura K Karmeli F Hayashi T Reinus C Rudensky B Akira S Takeda K Lee J Takabayashi K Raz E 《Gastroenterology》2004,126(2):520-528
BACKGROUND & AIMS: We tested whether the attenuation of experimental colitis by live probiotic bacteria is due to their immunostimulatory DNA, whether toll-like receptor (TLR) signaling is required, and whether nonviable probiotics are effective. METHODS: Methylated and unmethylated genomic DNA isolated from probiotics (VSL-3), DNAse-treated probiotics and Escherichia coli (DH5 alpha) genomic DNA were administered intragastrically (i.g.) or subcutaneously (s.c.) to mice prior to the induction of colitis. Viable or gamma-irradiated probiotics were administered i.g. to wild-type mice and mice deficient in different TLR or in the adaptor protein MyD88, 10 days prior to administration of dextran sodium sulfate (DSS) to their drinking water and for 7 days thereafter. RESULTS: Intragastric and s.c. administration of probiotic and E. coli DNA ameliorated the severity of DSS-induced colitis, whereas methylated probiotic DNA, calf thymus DNA, and DNase-treated probiotics had no effect. The colitis severity was attenuated to the same extent by i.g. delivery of nonviable gamma-irradiated or viable probiotics. Mice deficient in MyD88 did not respond to gamma-irradiated probiotics. The severity of DSS-induced colitis in TLR2 and TLR4 deficient mice was significantly decreased by i.g. administration of gamma-irradiated probiotics, whereas, in TLR9-deficient mice, gamma-irradiated probiotics had no effect. CONCLUSIONS: The protective effects of probiotics are mediated by their own DNA rather than by their metabolites or ability to colonize the colon. TLR9 signaling is essential in mediating the anti-inflammatory effect of probiotics, and live microorganisms are not required to attenuate experimental colitis because nonviable probiotics are equally effective. 相似文献
142.
Pietersz RN Reesink HW Panzer S Gilbertson MP Borosak ME Wood EM Leitner GC Rabitsch W Ay C Lambermont M Deneys V Sondag D Compernolle V Legrand D François A Tardivel R Garban F Sawant RB Rebulla P Handa M Ohto H Kerkhoffs JL Brand A Zhiburt E Cid J Escolar G Lozano M Puig L Knutson F Hallböök H Lubenow N Estcourt L Stanworth S Murphy MF Williams L Mraz DL Ross RL Snyder E 《Vox sanguinis》2012,103(2):159-176
143.
Hamza Berguigua Ludovic Iche Philippe Roche Cyril Aubert Renaud Blond Antoine Legrand Brnice Puech Chlo Combe Charles Vidal Margot Caron Marie-Christine Jaffar-Bandjee Christophe Caralp Nora Oulehri Hugo Kerambrun Jrme Allyn Yvonnick Bou Nicolas Allou 《Medicine》2021,100(48)
In February 2021, an explosion of cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia overwhelmed the only hospital in Mayotte. To report a case series of patients with acute respiratory failure (ARF) due to SARS-CoV-2 who were evacuated by air from Mayotte to Reunion Island.This retrospective observational study evaluated all consecutive patients with ARF due to SARS-CoV-2 who were evacuated by air from Mayotte Hospital to the intensive care unit (ICU) of Félix Guyon University Hospital in Reunion Island between February 2, and March 5, 2021.A total of 43 patients with SARS-CoV-2 pneumonia were evacuated by air, for a total flight time of 2 hours and a total travel time of 6 hours. Of these, 38 patients (88.4%) with a median age of 55 (46–65) years presented with ARF and were hospitalized in our ICU. Fifteen patients were screened for the SARS-CoV-2 501Y.V2 variant, all of whom tested positive. Thirteen patients (34.2%) developed an episode of severe hypoxemia during air transport, and the median paO2/FiO2 ratio was lower on ICU admission (140 [102–192] mmHg) than on departure (165 [150–200], P = .022). Factors associated with severe hypoxemia during air transport was lack of treatment with curare (P = .012) and lack of invasive mechanical ventilation (P = .003). Nine patients (23.7%) received veno-venous extracorporeal membrane oxygenation support in our ICU. Seven deaths (18.4%) occurred in hospital.Emergency air evacuation of patients with ARF due to SARS-CoV-2 was associated with severe hypoxemia but remained feasible. In cases of ARF due to SARS-CoV-2 requiring emergency air evacuation, sedated patients receiving invasive mechanical ventilation and curare should be prioritized over nonintubated patients. It is noteworthy that patients with SARS-CoV-2 pneumonia related to the 501Y.V2 variant were very severe despite their young age. 相似文献
144.
145.
Hengameh Abdollahpour Malik Alawi Fanny Kortüm Michael Beckstette Eva Seemanova Vladimír Komárek Georg Rosenberger Kerstin Kutsche 《European journal of human genetics : EJHG》2015,23(2):256-259
The recently proposed adaptor protein 4 (AP-4) deficiency syndrome comprises a group of congenital neurological disorders characterized by severe intellectual disability (ID), delayed or absent speech, hereditary spastic paraplegia, and growth retardation. AP-4 is a heterotetrameric protein complex with important functions in vesicle trafficking. Mutations in genes affecting different subunits of AP-4, including AP4B1, AP4E1, AP4S1, and AP4M1, have been reported in patients with the AP-4 deficiency phenotype. We describe two siblings from a non-consanguineous couple who presented with severe ID, absent speech, microcephaly, growth retardation, and progressive spastic tetraplegia. Whole-exome sequencing in the two patients identified the novel homozygous 2-bp deletion c.1160_1161delCA (p.(Thr387Argfs*30)) in AP4B1. Sanger sequencing confirmed the mutation in the siblings and revealed it in the heterozygous state in both parents. The AP4B1-associated phenotype has previously been assigned to spastic paraplegia-47. Identification of a novel AP4B1 alteration in two patients with clinical manifestations highly similar to other individuals with mutations affecting one of the four AP-4 subunits further supports the observation that loss of AP-4 assembly or functionality underlies the common clinical features in these patients and underscores the existence of the clinically recognizable AP-4 deficiency syndrome. 相似文献
146.
Alexandre O. Grard Diane Merino Elise K. Van Obberghen Fanny Rocher Alexandre Destere Michel Lantri-Minet Milou-Daniel Drici 《The journal of headache and pain》2022,23(1)
BackgroundMigraine is responsible for significant disability and societal burden. Recently, drugs targeting the calcitonin gene-related peptide (CGRP) pathway raised new hopes. CGRP, a potent vasodilator, plays a key role in the pathogenesis of migraine attacks. The deficiency of CGRP is involved in Raynaud’s phenomenon, which consists of abnormal vasoconstriction of the digits. We aimed to assess the potential association of Raynaud’s phenomenon with CGRP-targeting drugs, analyzing real-world data from the World Health Organization (VigiBase®).MethodsWe queried all reports of Raynaud’s phenomenon involving a CGRP-targeting drug. We sought disproportionate reporting of Raynaud’s phenomenon with these drugs. For this purpose, we relied on the calculation of the Information Component (IC). A positive lower end of the 95% confidence interval (CI) of the IC defines a statistically significant association. As migraine patients are prone to Raynaud’s phenomenon, we also calculated the IC of Raynaud’s phenomenon with CGRP-targeting drugs compared to 5HT1B/D agonists (triptans), and beta-blockers used in the treatment of migraine.ResultsOverall, 99 reports of Raynaud’s phenomenon involving CGRP-targeting drugs have been yielded in VigiBase®. The most reported CGRP-targeting drug was erenumab, with 56 reports (56.6%). The median time to onset was 84 days. No fatality was notified, but one patient suffered from gangrene and extremity necrosis. As a whole, CGRP-targeting drugs were significantly associated with Raynaud’s phenomenon, with an IC of 3.3 (95%CI: 3.0–3.5). There was a disproportionate reporting of Raynaud’s phenomenon with CGRP-targeting drugs compared to triptans (IC 0.4; 95%CI: 0.1–0.6) and to beta-blockers (IC 0.5; 95%CI: 0.2–0.7) as well.ConclusionsThere is a significant disproportionality signal of Raynaud’s phenomenon with CGRP-targeting. This signal stands out when CGRP-targeting drugs are compared to other drugs used in patients with migraine. This study is limited by missing data in pharmacovigilance reports. CGRP-targeting drugs may be subject to Weber effect and reporting bias. Nonetheless, CGRP blockade might be the last straw that disrupts the physiological balance of vascular response in patients at-risk of Raynaud’s phenomenon. Pending further data regarding vascular safety of CGRP-targeting drugs, caution is warranted in these patients. 相似文献
147.
Interleukin 6 in Intact and Injured Mouse Peripheral Nerves 总被引:4,自引:0,他引:4
Fanny Reichert Rubina Levitzky Shlomo Rotshenker 《The European journal of neuroscience》1996,8(3):530-535
The multifunctional cytokine interleukin 6 (IL-6) has direct growth, survival and differentiation effects on peripheral and central neurons. Furthermore, it can modulate the production by non-neuronal cells of other cytokines and growth factors, and thereby affect nerve cells indirectly. We have studied IL-6 expression and production in intact and injured peripheral nerves of C57/BL/6NHSD mice, which display the normal rapid progression of Wallerian degeneration. The IL-6 mRNA was detected in nerves degenerating in vitro or in vivo , but not in intact nerves. In vitro - and in vivo -degenerating nerve segments and neuroma nerve segments synthesized and secreted IL-6. The onset of IL-6 production was rapid and prolonged. It was detected as early as 2 h after injury and persisted for the entire period of 21 days tested after the injury. Of the non-neuronal cells that reside in intact and injured nerves, macrophages and fibroblasts were the major contributors to IL-6 production. We also studied IL-6 production in intact and injured nerves of mutant C57BL/6-WLD/OLA/NHSD mice, which display very slow progression of Wallerian degeneration. Injured nerves of C57BL/6-WLD/OLA/NHSD mice produced significantly lower amounts of IL-6 than did rapidly degenerating nerves of C57/BL/6NHSD mice. 相似文献
148.
149.
150.